Get In Touch

The pericarditis drugs market is estimated to serve good growth opportunities across the assessment period of 2021-2031. The escalating adoption of dual therapy, product approvals, advent of biologics, and the increasing cases of idiopathic pericarditis will bring immense growth opportunities for the pericarditis drugs market during the forecast period of 2021-2031.

  • The extensive advancements in the treatment and the diagnosis of cardiovascular diseases will bring exponential growth for the pericarditis drugs market. The advancements in the biologics sector will also bring expansive growth prospects during the tenure of 2021-2031.
  • Research and development activities have an important part in the growth of the pericarditis drugs market. The rising use of these drugs has led to intense concentration of the players on research. The activities help in deriving new formulations that boost the growth opportunities across the pericarditis drugs market to a considerable extent. All these factors bode well for the growth of the pericarditis drugs market.
  • Strategic collaborations are crucial for the pericarditis drugs market. The players are involved in mergers and acquisitions for cementing their foothold across the pericarditis drugs market, eventually sowing the seeds of growth.

Pericardium, a thin sac, surrounds the human heart. The pericardial cavities take place between the fluid-filled layers (fibrous and serous pericardium). The key function of the pericardium is to safeguard and lubricate the heart in place within the cavity of the chest. Other than this, it also prevents the heart from stretching too much, restrains friction with other tissues around during heart-beating, and protects it from infections. But once pericardium is inflamed with fluid it can harm and disturb the routine functions of the heart. The swelling in the pericardium is pericarditis which can be of two types: acute and chronic. A rapid rise in emergency cases due to chest pain has fueled the pericarditis drugs market.

In the condition of constrictive pericarditis along with shortness of breath, swelling of abdomen, legs, and feet, and heart palpitations, immediate medication is required. So as per laboratory investigations, non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin should be recommended to patients. As an adjunct to NSAIDs, colchicine is also suggested as first-line therapy to its treatment. With multiple medication options available for the treatment of disease, the pericarditis drugs market may witness new avenues. The arrival of biologics, adoption of dual therapy, marked prevalence of idiopathic pericarditis, and product approvals are responsible for the anticipated expansion of the pericarditis drugs market.

Pericarditis Drugs Market: Introduction

  • Pericarditis is inflammation of the pericardium. Pericardium is two thin layers of a sac like structure of tissues that surrounds the heart. The pericardium holds the heart in place and helps it work. It has small amount of fluid that keeps both the layers separated from each other so that there is no friction between the layers. Pericarditis often causes chest pain and other symptoms. The harsh chest pain associated with pericardium occurs when the layers of the pericardium rub against each other. Pericarditis usually begins suddenly, but does not last for long.
  • Chronic pericarditis is when symptoms related to pericarditis develop more gradually or persist. Most cases of pericarditis are mild and usually improve on their own. Common symptoms related of pericarditis are cough, leg or abdominal swelling, low-grade fever, heart palpitations, shortness of breath when reclining, an overall sense of weakness, feeling sick or fatigue, and sharp, piercing chest pain. Pericarditis can be diagnosed with the help of electrocardiogram, echocardiogram, physical examination, cardiac MRI, and reported symptoms.

Key Drivers, Restrains, and Opportunities of Global Pericarditis Drugs Market

  • Rise in prevalence of cardiovascular diseases and pericarditis is expected to drive the demand for pericarditis drugs. According to Cureus, an open access medical journal for a new generation of doctors and patients, acute pericarditis is the most common disease in several clinical settings. The incidence of acute pericarditis has been reported to be between 0.1% and 0.2% of hospitalized patients, and 5% of the patients were admitted to the emergency department with non-ischemic chest pain. Moreover, cardiovascular diseases account for 17.9 million deaths globally each year, constituting an estimated 31% of all deaths. Over 75% of cardiovascular deaths occur in low- and middle-income countries.
  • Adoption of dual therapy for the treatment of idiopathic pericarditis is a key factor propelling the global pericarditis drugs market. Conventionally, aspirin as monotherapy is used to treat acute pericarditis. However, clinical trials are being carried out for dual therapy with the combination of two drugs — aspirin with colchicine — for the treatment of pericarditis. The results have shown that combination therapy is effective in reducing the recurrence rate of pericarditis compared to conventional monotherapy.
  • Therefore, adoption of dual therapy such as aspirin with colchicine is anticipated to increase due to rise in prevalence of idiopathic pericarditis with repeated episodes. However, side effects of anti-inflammatory drugs, presence of misbranded drugs, surgical intervention, and stringent government rules and regulations are expected to hamper the growth of the global pericarditis drugs market during the forecast period.

North America to Capture Major Share of Global Pericarditis Drugs Market

  • North America is anticipated to account for major share of the global pericarditis drugs market during the forecast period. This is attributed to large number of people diagnosed with cardiac disorders and substantial R&D and health care spending. Moreover, increase in awareness about cardiovascular disorders is expected to boost the growth of the market in North America.
  • The pericarditis drugs market in Asia Pacific is likely to grow at a rapid pace during the forecast period owing to rise in number of cardiac surgeries, increase in patients with cardiovascular disorders, and expanding health care infrastructure

Key Players Operating in Global Pericarditis Drugs Market

The global pericarditis drugs market is moderately fragmented due to the presence of larger number of international as well as local players. These players hold major market share in their respective regions.

Major players operating in the global pericarditis drugs market are:

  • AstraZeneca plc
  • Bayer AG
  • Johnson & Johnson
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Other prominent players

Global Pericarditis Drugs Market: Research Scope

Global Pericarditis Drugs Market, by Drug Type

  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Colchicine
  • Others

Global Pericarditis Drugs Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Pericarditis Drugs Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Pericarditis Drugs Market